STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc. - LBPH

Group 1 - Monteverde & Associates PC is investigating Longboard Pharmaceuticals, Inc. in relation to a tender offer from H. Lundbeck A/S, which proposes to acquire outstanding shares of Longboard common stock for $60.00 per share [1] - Monteverde & Associates PC has been recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report, indicating its successful track record in recovering money for shareholders [1][2] - The firm operates from the Empire State Building in New York City and specializes in class action securities litigation [2][3] Group 2 - The firm encourages shareholders with concerns regarding Longboard Pharmaceuticals to seek additional information free of charge [3] - Monteverde & Associates PC emphasizes that no company, director, or officer is above the law, reinforcing its commitment to shareholder rights [3]